Stephanie Baker1, Wei Xiang2, Ian Atkinson3. 1. College of Science & Engineering, James Cook University, Cairns, Queensland, Australia 4878, Australia. Electronic address: stephanie.baker@jcu.edu.au. 2. School of Engineering and Mathematical Sciences, La Trobe University, Melbourne, Victoria, Australia 3086, Australia. Electronic address: w.xiang@latrobe.edu.au. 3. eResearch Centre, James Cook University, Townsville, Queensland, Australia 4811, Australia. Electronic address: ian.atkinson@jcu.edu.au.
Abstract
BACKGROUND AND OBJECTIVES: Continuous and non-invasive blood pressure monitoring would revolutionize healthcare. Currently, blood pressure (BP) can only be accurately monitored using obtrusive cuff-based devices or invasive intra-arterial monitoring. In this work, we propose a novel hybrid neural network for the accurate estimation of blood pressure (BP) using only non-invasive electrocardiogram (ECG) and photoplethysmogram (PPG) waveforms as inputs. METHODS: This work proposes a hybrid neural network combines the feature detection abilities of temporal convolutional layers with the strong performance on sequential data offered by long short-term memory layers. Raw electrocardiogram and photoplethysmogram waveforms are concatenated and used as network inputs. The network was developed using the TensorFlow framework. Our scheme is analysed and compared to the literature in terms of well known standards set by the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI). RESULTS: Our scheme achieves extremely low mean absolute errors (MAEs) of 4.41 mmHg for SBP, 2.91 mmHg for DBP, and 2.77 mmHg for MAP. A strong level of agreement between our scheme and the gold-standard intra-arterial monitoring is shown through Bland Altman and regression plots. Additionally, the standard for BP devices established by AAMI is met by our scheme. We also achieve a grade of 'A' based on the criteria outlined by the BHS protocol for BP devices. CONCLUSIONS: Our CNN-LSTM network outperforms current state-of-the-art schemes for non-invasive BP measurement from PPG and ECG waveforms. These results provide an effective machine learning approach that could readily be implemented into non-invasive wearable devices for use in continuous clinical and at-home monitoring.
BACKGROUND AND OBJECTIVES: Continuous and non-invasive blood pressure monitoring would revolutionize healthcare. Currently, blood pressure (BP) can only be accurately monitored using obtrusive cuff-based devices or invasive intra-arterial monitoring. In this work, we propose a novel hybrid neural network for the accurate estimation of blood pressure (BP) using only non-invasive electrocardiogram (ECG) and photoplethysmogram (PPG) waveforms as inputs. METHODS: This work proposes a hybrid neural network combines the feature detection abilities of temporal convolutional layers with the strong performance on sequential data offered by long short-term memory layers. Raw electrocardiogram and photoplethysmogram waveforms are concatenated and used as network inputs. The network was developed using the TensorFlow framework. Our scheme is analysed and compared to the literature in terms of well known standards set by the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI). RESULTS: Our scheme achieves extremely low mean absolute errors (MAEs) of 4.41 mmHg for SBP, 2.91 mmHg for DBP, and 2.77 mmHg for MAP. A strong level of agreement between our scheme and the gold-standard intra-arterial monitoring is shown through Bland Altman and regression plots. Additionally, the standard for BP devices established by AAMI is met by our scheme. We also achieve a grade of 'A' based on the criteria outlined by the BHS protocol for BP devices. CONCLUSIONS: Our CNN-LSTM network outperforms current state-of-the-art schemes for non-invasive BP measurement from PPG and ECG waveforms. These results provide an effective machine learning approach that could readily be implemented into non-invasive wearable devices for use in continuous clinical and at-home monitoring.